ANI Pharmaceuticals Inc
SWB:BSFA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
ANI Pharmaceuticals Inc
SWB:BSFA
|
US |
|
S
|
Sumitomo Realty & Development Co Ltd
XMUN:RL2
|
JP |
|
E
|
E79 Gold Mines Ltd
ASX:E79
|
AU |
|
Industrial Bank Co Ltd
SSE:601166
|
CN |
|
Airtel Africa PLC
LSE:AAF
|
UK |
|
T
|
Tungray Technologies Inc
NASDAQ:TRSG
|
SG |
|
Gestamp Automocion SA
OTC:GMPUF
|
ES |
|
Reliance Sekuritas Indonesia Tbk PT
IDX:RELI
|
ID |
|
Shahi Shipping Ltd
BSE:526508
|
IN |
|
H
|
HA Sustainable Infrastructure Capital Inc
F:6HA
|
US |
|
Black Hills Corp
NYSE:BKH
|
US |
|
Blue Bird Corp
F:4RB
|
US |
|
Trivago NV
NASDAQ:TRVG
|
DE |
|
T
|
Topco Media Co Ltd
KOSDAQ:134580
|
KR |
|
One Stop Systems Inc
NASDAQ:OSS
|
US |
|
CNS Pharmaceuticals Inc
NASDAQ:CNSP
|
US |
|
P
|
Procorp SAB de CV
BMV:PROCORPB
|
MX |
|
Bioceres Crop Solutions Corp
NASDAQ:BIOX
|
AR |
|
Carlo Gavazzi Holding AG
SIX:GAV
|
CH |
|
Sailun Group Co Ltd
SSE:601058
|
CN |
|
Vbt Yazilim AS
IST:VBTYZ.E
|
TR |
|
Intel Corp
MIL:1INTC
|
US |
|
R
|
Ryman Healthcare Ltd
SWB:RH7
|
NZ |
|
PLDT Inc
NYSE:PHI
|
PH |
Bankruptcy Probability
ANI Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
ANI Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
ANI Pharmaceuticals Inc
NASDAQ:ANIP
|
1.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.3T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
651.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
391.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
366.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
174.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
202.8B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
128.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
ANI Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, ANI Pharmaceuticals Inc has total debt of 589.2m USD. This includes both short-term (0 USD) and long-term (589.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
